Results 211 to 220 of about 23,477,104 (364)
The Influence of Self‐Efficacy, Trust, Perceived Costs and Healthcare‐Environment on Compliance With the Data Protection and Privacy Act by Health Workers in Uganda [PDF]
Barbara N. Kayondo, Michael Kyobe
openalex +1 more source
A Study on Challenges of Data Security and Data Privacy in the Healthcare Sector: SWOT Analysis
, 2023 A. L. Prasuna, Avani Rachh
openalex +2 more sources
Arthritis Care &Research, Accepted Article.Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension‐phase). During part 1, three doses were assessed in two weight groups (Group A/B: ≥30–60 kg/≥10–<
Fabrizio De Benedetti +19 more
wiley +1 more source
The Ethical Data Practices Framework and Its Implications for Data Privacy Relations between the United States and the European Union. [PDF]
Am J Bioeth, 2023 Rahimzadeh V.
europepmc +1 more source
Privacy Fears on the Increase, warns Data Protection Commissioner
, 2003 Joe Meade
openalex +1 more source
Arthritis Care &Research, Accepted Article.Objective We evaluated the role of 25‐hydroxy vitamin D, prednisone and other risk factors for bone mineral density (BMD) loss and osteoporosis in systemic lupus erythematosus (SLE). Methods We calculated the association between 25‐hydroxy vitamin D [25(OH)D] levels and other potential risk factors with BMD measures (spine T‐scores) and osteoporosis ...
Nima Madanchi +4 more
wiley +1 more source
Enhancing healthcare data privacy and interoperability with federated learning. [PDF]
PeerJ Comput SciAkhmetov A, Latif Z, Tyler B, Yazici A.
europepmc +1 more source
Data privacy and management - A COVID legacy or curse? [PDF]
Int Wound J, 2022 Queen D.
europepmc +1 more source
Sex differences in medication discontinuation in axial spondyloarthritis.
Arthritis Care &Research, Accepted Article.Objective We examined sex differences in medication discontinuation among patients with axial spondyloarthritis (axSpA) initiating tumor necrosis factor inhibitors (TNFi), interleukin‐17 inhibitors (IL‐17i), or Janus kinase inhibitors (JAKi). Methods Using data from the Rheumatology Informatics System for Effectiveness (RISE) Registry (2003–2025), we ...
Rachael Stovall +9 more
wiley +1 more source